High-dose sulbactam for extensively drug-resistant Acinetobacter baumannii infection in patients with critical illness.
OBJECTIVES The therapeutic effect and tolerability of sulbactam, at a daily dose of at least 9 g, were assessed in critically ill individuals who acquired extensively drug-resistant Acinetobacter baumannii (XDR-AB) infection. METHODS This single-center retrospective cohort evaluated a primary composite endpoint of de...